Skip to main content
Clinical Trials/NCT03213743
NCT03213743
Completed
Not Applicable

Expression Profiling of microRNA Following Administration of Dexmedetomidine in Patients Undergoing Procedures

First Affiliated Hospital of Kunming Medical University1 site in 1 country3 target enrollmentJune 19, 2017

Overview

Phase
Not Applicable
Intervention
Dexmedetomidine Injection
Conditions
Coronary Disease
Sponsor
First Affiliated Hospital of Kunming Medical University
Enrollment
3
Locations
1
Primary Endpoint
microRNA differential expression
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

The purpose of the study is to find out the differential expression profiling of microRNA before and after adiministration of dexmedetomidine in patients undergoing procedures, and then investigators will do some in vitro studies to validate the functions of the microRNA.

Detailed Description

Background and objective: The use of dexmedetomidine may have benefits on the clinical outcomes of cardiac surgery. MicroRNAs are non-coding RNA sequences that act as regulators of gene expression. Investigators conduct a study to determine the role of microRNAs in cardioprotection mediated by dexmedetomidine. Methods: In this study 3 patients were selected. The blood sample were taken before administration of dexmedetomidine.Investigators infused loading dose of dexmedetomidine for 10 minutes and maintaining dese of dexmedetomidine for 20 minutes.Thirty minutes after the administration, another blood samples were taken and stored in the liquid nitrogen and both the samples were marked. Those sample were analyzed for differentially expressed microRNA with Exiqon miRNA Array.

Registry
clinicaltrials.gov
Start Date
June 19, 2017
End Date
June 21, 2017
Last Updated
8 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
First Affiliated Hospital of Kunming Medical University
Responsible Party
Principal Investigator
Principal Investigator

Jinqiao Qian

Professor

First Affiliated Hospital of Kunming Medical University

Eligibility Criteria

Inclusion Criteria

  • The patients without arrithmia will undergo procedure.

Exclusion Criteria

  • The patients have bradycardia (hear rate is less than 60 beats per minute) or conduction block.

Arms & Interventions

before dexmedetomidine

We took blood samples before the administration of dexmedetomidine to determine exression level of microRNA in the subjects.

Intervention: Dexmedetomidine Injection

Outcomes

Primary Outcomes

microRNA differential expression

Time Frame: 30 minutes

microRNA differential expression exerts cardioprotection effect on patients undergoing procedures.

Study Sites (1)

Loading locations...

Similar Trials